3 More Neil Woodford Core Picks For Your ISA: GlaxoSmithKline plc, Legal & General Group Plc & Imperial Brands PLC

Woodford core holdings GlaxoSmithKline plc (LON:GSK), Legal & General Group Plc (LON:LGEN) and Imperial Brands PLC (LON:IMB) could be great picks for your ISA.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investors have plenty to worry about at the moment what with the upcoming UK referendum on EU membership, volatile commodity markets and a growth slowdown in China.

However, top fund manager Neil Woodford continues to believe that his equity income fund’s core blue-chip companies can still deliver in an uncertain and low-growth world.

If you’re looking for shares for your ISA in these difficult times, GlaxoSmithKline (LSE: GSK), Legal & General (LSE: LGEN) and Imperial Brands (LSE: IMB) — three Woodford core holdings — have a lot going for them.

GlaxoSmithKline

A Woodford fund update almost a year ago said: “GlaxoSmithKline is a long-term holding and one which has been frustratingly disappointing for much of the holding period”.

Last month, Glaxo reported a further decline in earnings in its annual results, the share price remains depressed … and Woodford and his team maintain their faith, saying recently: We continue to see substantial long-term value, believing that the sum of Glaxo’s constituent parts is significantly greater than the whole, as reflected by the current share price”.

Indeed, Woodford, and a number of other major shareholders, have for some time been calling for a radical, value-unlocking restructuring of Glaxo: a break-up, or partial break-up, of the four-business conglomerate.

An announcement last week that chief executive Sir Andrew Witty will retire in March next year could open the door for change. Not surprisingly, Woodford has expressed a “strong preference for an external candidate” to replace Witty.

Glaxo has decent prospects in its present form, with a return to growth expected this year, but there’s potential for shareholder returns to be significantly enhanced by the kind of restructuring Woodford and others are pressing for.

Legal & General

Insurer and asset manager Legal & General has seen its shares under pressure this year. The market has been concerned about the company’s corporate bond portfolio in an environment of deteriorating credit quality in the asset class, particularly in the troubled oil and mining sectors.

Woodford and his team are less concerned, saying early this month: We are reassured about its quality and diversity. We see [L&G’s] recent weakness as unjustified, given its strong cash generation, high yield and the fact that it looks well placed to deliver attractive rates of dividend growth.”

L&G has subsequently released results showing cash generation up 14% and a 19% dividend increase, giving ample support to Woodford’s view.

Imperial Brands

Imperial Brands has recently changed its name from Imperial Tobacco, but the business hasn’t changed and neither has Woodford’s positive view on the industry and the company.

Stephen Lamacraft, the Woodford team’s mature blue-chip specialist, recently reiterated that: “Tobacco has, over the years, proven itself to be an extremely dependable industry — delivering steady and sustainable growth in cash flows, earnings and dividends year in, year out, regardless of the economic environment”.

As far as Imperial Tobacco, in particular, is concerned, he added that last month’s trading update demonstrates “the stock’s attractive and dependable growth characteristics”.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Google office headquarters
Investing Articles

1 reason I like buying S&P 500 shares – and 1 reason I don’t

Will this investor try to improve his potential returns by focusing more on S&P 500 shares instead of British ones?…

Read more »

Young woman holding up three fingers
Investing Articles

3 SIPP mistakes to avoid

Our writer explains a trio of potentially costly errors he tries to avoid making when investing his SIPP, on an…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

Here’s how (and why) I’d start buying shares with £25 a week

Our writer uses his investment experience and current approach to explain how he would start buying shares on a limited…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Here’s my 5-step approach to earning passive income of £500 a month

Christopher Ruane explains the handful of steps he uses to target hundreds of pounds in passive income each month.

Read more »

Investing Articles

2 UK shares I’ve been buying this week

From a value perspective, UK shares look attractive. But two in particular have been attracting Stephen Wright’s attention over the…

Read more »

Investing Articles

A lifelong second income for just £10 a week? Here’s how!

With a simple, structured approach to buying blue-chip dividend shares at attractive prices, our writer's building a second income for…

Read more »

Investing Articles

Here’s how I’d use a £20k Stocks and Shares ISA to help build generational wealth

Discover how our writer would aim to turn a £20k Stocks and Shares ISA into a sizeable nest egg by…

Read more »